Compare BLTE & MDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLTE | MDA |
|---|---|---|
| Founded | 2018 | 1969 |
| Country | United States | Canada |
| Employees | N/A | 4000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Electronic Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 5.7B |
| IPO Year | 2021 | 2026 |
| Metric | BLTE | MDA |
|---|---|---|
| Price | $154.79 | $32.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $198.00 | $37.50 |
| AVG Volume (30 Days) | 146.1K | ★ 1.9M |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $12.11 |
| Revenue Next Year | $492.11 | $11.03 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $60.00 | $23.23 |
| 52 Week High | $200.00 | $49.37 |
| Indicator | BLTE | MDA |
|---|---|---|
| Relative Strength Index (RSI) | 51.22 | 45.34 |
| Support Level | $145.11 | $29.10 |
| Resistance Level | $160.72 | $42.24 |
| Average True Range (ATR) | 6.09 | 1.63 |
| MACD | 0.05 | 0.13 |
| Stochastic Oscillator | 52.71 | 54.70 |
Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.
MDA Space Ltd is a developer and manufacturer of technology and services to the space industry. It is an international space mission partner and robotics, satellite systems, and geo-intelligence pioneer. It is engaged in communications satellites, Earth and space observation, space exploration, and infrastructure. The Company collaborates and partners with governments and space agencies, commercial space companies, and defence and aerospace prime contractors in the space industry. Geographically, it generates the majority of its revenue from Canada.